TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013
TCL Archive Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years March 6, 1998